356 related articles for article (PubMed ID: 16522582)
1. Estimating the cost of new drug development: is it really 802 million dollars?
Adams CP; Brantner VV
Health Aff (Millwood); 2006; 25(2):420-8. PubMed ID: 16522582
[TBL] [Abstract][Full Text] [Related]
2. The price of innovation: new estimates of drug development costs.
DiMasi JA; Hansen RW; Grabowski HG
J Health Econ; 2003 Mar; 22(2):151-85. PubMed ID: 12606142
[TBL] [Abstract][Full Text] [Related]
3. Spending on new drug development1.
Adams CP; Brantner VV
Health Econ; 2010 Feb; 19(2):130-41. PubMed ID: 19247981
[TBL] [Abstract][Full Text] [Related]
4. Scale and scope in drug development: unpacking the advantages of size in pharmaceutical research.
Cockburn IM; Henderson RM
J Health Econ; 2001 Nov; 20(6):1033-57. PubMed ID: 11758047
[TBL] [Abstract][Full Text] [Related]
5. New estimates of drug development costs.
Frank RG
J Health Econ; 2003 Mar; 22(2):325-30. PubMed ID: 12606149
[No Abstract] [Full Text] [Related]
6. Returns to R&D on new drug introductions in the 1980s.
Grabowski HG; Vernon JM
J Health Econ; 1994 Dec; 13(4):383-406. PubMed ID: 10140531
[TBL] [Abstract][Full Text] [Related]
7. Drug costs: research and development costs: the great illusion.
Prescrire Int; 2004 Feb; 13(69):32-6. PubMed ID: 15055226
[TBL] [Abstract][Full Text] [Related]
8. Costing drug development.
Nat Rev Drug Discov; 2003 Apr; 2(4):247. PubMed ID: 12680358
[No Abstract] [Full Text] [Related]
9. Support for trials of promising medications through the Pharmaceutical Benefits Scheme.
Flecknoe-Brown SC
Med J Aust; 1995 Apr; 162(8):447. PubMed ID: 7746193
[No Abstract] [Full Text] [Related]
10. Drug development cost estimates hard to swallow.
Collier R
CMAJ; 2009 Feb; 180(3):279-80. PubMed ID: 19188620
[No Abstract] [Full Text] [Related]
11. Research and Development Spending to Bring a Single Cancer Drug to Market and Revenues After Approval.
Prasad V; Mailankody S
JAMA Intern Med; 2017 Nov; 177(11):1569-1575. PubMed ID: 28892524
[TBL] [Abstract][Full Text] [Related]
12. Market watch: Upcoming market catalysts in Q3 2016.
Ranj T
Nat Rev Drug Discov; 2016 Jul; 15(7):449. PubMed ID: 27282354
[No Abstract] [Full Text] [Related]
13. Editor's note: Industry support of articles published in Mayo Clinic Proceedings.
Lanier WL
Mayo Clin Proc; 2006 Jun; 81(6):851-2. PubMed ID: 16832914
[No Abstract] [Full Text] [Related]
14. More Chinese get free drugs in clinical trials.
Berton E
Wall St J (East Ed); 2006 Feb; ():B1, B8. PubMed ID: 16528877
[No Abstract] [Full Text] [Related]
15. Drug companies cut costs with foreign clinical trials.
Rai S
N Y Times Web; 2005 Feb; ():C4. PubMed ID: 15742516
[No Abstract] [Full Text] [Related]
16. Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018.
Wouters OJ; McKee M; Luyten J
JAMA; 2020 Mar; 323(9):844-853. PubMed ID: 32125404
[TBL] [Abstract][Full Text] [Related]
17. [Does the public sector have an independent research role in the development of drugs?].
Poulsen HE; Grønlykke TB
Ugeskr Laeger; 2003 Apr; 165(16):1674-6. PubMed ID: 12756828
[TBL] [Abstract][Full Text] [Related]
18. How some patients in new-drug trials can get cut off.
Anand G
Wall St J (East Ed); 2003 Dec; ():A1, A11. PubMed ID: 14971381
[No Abstract] [Full Text] [Related]
19. The distribution of sales revenues from pharmaceutical innovation.
Grabowski HG; Vernon J
Pharmacoeconomics; 2000; 18 Suppl 1():21-32. PubMed ID: 11151306
[TBL] [Abstract][Full Text] [Related]
20. Estimated Costs of Pivotal Trials for Novel Therapeutic Agents Approved by the US Food and Drug Administration, 2015-2016.
Moore TJ; Zhang H; Anderson G; Alexander GC
JAMA Intern Med; 2018 Nov; 178(11):1451-1457. PubMed ID: 30264133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]